Stocks News

LAST PRICE
309.8200
TODAY'S CHANGE (%)
Trending Down-1.6000 (-0.5138%)

Bid / Lots
296.8800/ 1
Ask / Lots
316.2000/ 1
Open / Previous Close
312.3200 / 311.4200
Day Range
Low 308.1450
High 313.4200
52 Week Range
Low 215.9600
High 335.8300
Volume
955,770
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- DJ HCA Healthcare Is Maintained at Buy by TD Cowen, from 12 hours ago by Dow Jones
  12 hours ago by Dow Jones
  Companies Mentioned: HCA
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HCA/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 30, 2024 11:19 ET (15:19 GMT)
- TD Cowen Adjusts Price Target on HCA Healthcare to $360 From $371, from 16 hours ago by MT Newswires
  16 hours ago by MT Newswires
  Companies Mentioned: HCA
  07:01 AM EDT, 04/30/2024 (MT Newswires) -- HCA Healthcare (HCA) has an average rating of outperform and price targets ranging from $285 to $378, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research...
Yesterday
- DJ HCA Healthcare Is Maintained at Overweight by Barclays, from 11:51AM ET on Monday Apr 29, 2024 by Dow Jones
  11:51AM ET on Monday Apr 29, 2024 by Dow Jones
  Companies Mentioned: HCA
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HCA/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 29, 2024 11:51 ET (15:51 GMT)
- DJ HCA Healthcare Is Maintained at Outperform by RBC Capital, from 10:17AM ET on Monday Apr 29, 2024 by Dow Jones
  10:17AM ET on Monday Apr 29, 2024 by Dow Jones
  Companies Mentioned: HCA
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HCA/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 29, 2024 10:17 ET (14:17 GMT)
- Leerink Partners Adjusts Price Target on HCA Healthcare to $367 From $354, from 9:29AM ET on Monday Apr 29, 2024 by MT Newswires
  9:29AM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: HCA
  09:29 AM EDT, 04/29/2024 (MT Newswires) -- HCA Healthcare (HCA) has an average outperform rating and a price target range of $285 to $378, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from ...

Today
- Baird Adjusts Laboratory Corp of America Holdings' Price Target to $255 From $244, from 15 hours ago by MT Newswires
  15 hours ago by MT Newswires
  Companies Mentioned: LH
- Baird Adjusts Quest Diagnostics' Price Target to $144 From $138, from 15 hours ago by MT Newswires
  15 hours ago by MT Newswires
  Companies Mentioned: DGX
- BNP Paribas Exane Adjusts Welltower's Price Target to $107 From $104, Keeps Outperform Rating, from 18 hours ago by MT Newswires
  18 hours ago by MT Newswires
  Companies Mentioned: WELL
Yesterday
- Welltower Q1 Normalized FFO, Revenue Increase, from 4:47PM ET on Monday Apr 29, 2024 by MT Newswires
  4:47PM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: WELL
- -- Earnings Flash (WELL) WELLTOWER Posts Q1 Revenue $1.86B, from 4:23PM ET on Monday Apr 29, 2024 by MT Newswires
  4:23PM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: WELL
- Equities Higher as Traders Await This Week's Key Earnings, Fed Decision, from 3:46PM ET on Monday Apr 29, 2024 by MT Newswires
  3:46PM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: WELL, KO, LLY, LOGI, MCD, PFE, NXPI, AAPL, PARA, PARAA, AMD, AMZN, MA
- Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy, from 10:17AM ET on Monday Apr 29, 2024 by MT Newswires
  10:17AM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: LH, PFE
- Evercore ISI Adjusts Price Target on Ventas to $49 From $50, from 7:40AM ET on Monday Apr 29, 2024 by MT Newswires
  7:40AM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: VTR
- Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B, from 7:03AM ET on Monday Apr 29, 2024 by PR Newswire
  7:03AM ET on Monday Apr 29, 2024 by PR Newswire
  Companies Mentioned: LH
Apr 26, 2024
- Baird Adjusts Laboratory Corp of America Holdings' Price Target to $244 From $255, from 11:14AM ET on Friday Apr 26, 2024 by MT Newswires
  11:14AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: LH

HCA Healthcare Inc
NYSE:HCAUnited States

Search Criteria

Today

DJ HCA Healthcare Is Maintained at Buy by TD Cowen, from 12 hours ago by Dow Jones

TD Cowen Adjusts Price Target on HCA Healthcare to $360 From $371, from 16 hours ago by MT Newswires

Yesterday

DJ HCA Healthcare Is Maintained at Overweight by Barclays, from 11:51AM ET on Monday Apr 29, 2024 by Dow Jones

DJ HCA Healthcare Is Maintained at Outperform by RBC Capital, from 10:17AM ET on Monday Apr 29, 2024 by Dow Jones

Leerink Partners Adjusts Price Target on HCA Healthcare to $367 From $354, from 9:29AM ET on Monday Apr 29, 2024 by MT Newswires

Peers Headlines

Today

Baird Adjusts Laboratory Corp of America Holdings' Price Target to $255 From $244, from 15 hours ago by MT Newswires

Baird Adjusts Quest Diagnostics' Price Target to $144 From $138, from 15 hours ago by MT Newswires

BNP Paribas Exane Adjusts Welltower's Price Target to $107 From $104, Keeps Outperform Rating, from 18 hours ago by MT Newswires

Yesterday

Welltower Q1 Normalized FFO, Revenue Increase, from 4:47PM ET on Monday Apr 29, 2024 by MT Newswires

-- Earnings Flash (WELL) WELLTOWER Posts Q1 Revenue $1.86B, from 4:23PM ET on Monday Apr 29, 2024 by MT Newswires

Equities Higher as Traders Await This Week's Key Earnings, Fed Decision, from 3:46PM ET on Monday Apr 29, 2024 by MT Newswires

Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy, from 10:17AM ET on Monday Apr 29, 2024 by MT Newswires

Evercore ISI Adjusts Price Target on Ventas to $49 From $50, from 7:40AM ET on Monday Apr 29, 2024 by MT Newswires

Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B, from 7:03AM ET on Monday Apr 29, 2024 by PR Newswire

Apr 26, 2024

Baird Adjusts Laboratory Corp of America Holdings' Price Target to $244 From $255, from 11:14AM ET on Friday Apr 26, 2024 by MT Newswires